Drug Interaction Report
3 potential interactions and/or warnings found for the following 2 drugs:
- cladribine
- lorlatinib
Interactions between your drugs
cladribine lorlatinib
Applies to: cladribine, lorlatinib
Lorlatinib may reduce the blood levels and effects of cladribine. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Let your doctor know if cladribine becomes less effective or is no longer controlling your symptoms. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
lorlatinib food
Applies to: lorlatinib
Do not consume grapefruit or grapefruit juice during treatment with lorlatinib. Grapefruit juice can significantly increase the blood levels and effects of lorlatinib, which may result in a greater risk of side effects. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
cladribine food
Applies to: cladribine
Cladribine oral products can bind to other medications. This may increase your risk of experiencing side effects. To avoid or minimize the interaction, cladribine should be taken at least 3 hours before or after other medications. Talk to your doctor if you have any questions or concerns, or if you have trouble separating the dosing times. Your doctor may be able to prescribe alternatives that do not interact. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Mavenclad
Mavenclad (cladribine) is used for the treatment of multiple sclerosis. Mavenclad information ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Zanaflex
Zanaflex (tizanidine) is a short-acting muscle relaxer used to treat spasticity by temporarily ...
Lioresal
Lioresal is used for chronic spasticity, muscle spasm, spasticity, spinal spasticity
Gablofen
Gablofen (baclofen) is used to treat severe spasticity. Includes Gablofen side effects ...
Lyvispah
Lyvispah is used to treat muscle stiffness, spasms, and pain from multiple sclerosis. It may also ...
Fleqsuvy
Fleqsuvy is used for chronic spasticity, muscle spasm, spasticity, spinal spasticity
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.